Smac Mimetic-Derived Augmentation of Chemotherapeutic Response in Experimental Pancreatic Cancer

BMC Cancer - United Kingdom
doi 10.1186/1471-2407-11-15
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Smac Mimetic Increases Chemotherapy Response and Improves Survival in Mice With Pancreatic Cancer

Cancer Research
Cancer ResearchOncology
2010English

miRNA Predictors of Pancreatic Cancer Chemotherapeutic Response: A Systematic Review and Meta-Analysis

Cancers
Cancer ResearchOncology
2019English

Conjugation to SMAC Mimetic Potentiates Sigma-2 Ligand Induced Tumor Cell Death in Ovarian Cancer

Gynecologic Oncology
GynecologyOncologyObstetrics
2014English

Biomarker Profile for Prediction of Response to SMAC Mimetic Monotherapy in Pediatric Precursor B‐Cell Acute Lymphoblastic Leukemia

International Journal of Cancer
Cancer ResearchOncology
2019English

3,3'-Diindolylmethane Enhances Chemosensitivity of Multiple Chemotherapeutic Agents in Pancreatic Cancer

Cancer Research
Cancer ResearchOncology
2009English

Design, Synthesis, and Evaluation of a Potent, Cell-Permeable, Conformationally Constrained Second Mitochondria Derived Activator of Caspase (Smac) Mimetic

English

Parkin-Independent Mitophagy Controls Chemotherapeutic Response in Cancer Cells

Cell Reports
BiochemistryGeneticsMolecular Biology
2017English

Emerging Role of Platelet-Derived Growth Factor Receptor- Inhibition in Radioimmunotherapy of Experimental Pancreatic Cancer

Clinical Cancer Research
Cancer ResearchOncology
2007English

SMAC Mimetic Debio 1143 and Ablative Radiation Therapy Synergize to Enhance Anti-Tumor Immunity Against Lung Cancer

Clinical Cancer Research
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy